Health News from Medical News Today: Fraunhofer USA CMB Announces Positive Phase 1 Interim Results For Its Plant-Produced H1N1 Influenza Vaccine

Health News from Medical News Today Latest Health News and Medical News posted throughout the day, every day. Fraunhofer USA CMB Announces Positive Phase 1 Interim Results For Its Plant-Produced H1N1 Influenza Vaccine 3 Jun 2011, 6:00 pm Fraunhofer USA Center for Molecular Biotechnology (CMB), a not-for-profit, Delaware-based organization focused on developing a proprietary plant-based protein production platform and its applications in vaccine and therapeutic fields, today announced positive interim results from the first human trial of plant-produced H1N1 influenza vaccine (HAC1) that began on September 13, 2010. This Phase 1, single-blind, placebo-controlled, dose-escalation study was conducted to assess the safety and reactogenicity and immunogenicity of CMB's HAC1... You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed.